Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for February 20, 2014


Shutterstock photo

Teva Pharmaceutical Industries Limited ( TEVA ) will begin trading ex-dividend on February 20, 2014. A cash dividend payment of $0.34 per share is scheduled to be paid on March 10, 2014. Shareholders who purchased TEVA stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 4.29% increase over the prior quarter.

The previous trading day's last sale of TEVA was $45.67, representing a -1.97% decrease from the 52 week high of $46.59 and a 25.95% increase over the 52 week low of $36.26.

TEVA is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). TEVA's current earnings per share, an indicator of a company's profitability, is $1.5. Zacks Investment Research reports TEVA's forecasted earnings growth in 2014 as -9.46%, compared to an industry average of 9%.

For more information on the declaration, record and payment dates, visit the TEVA Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to TEVA through an Exchange Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:

  • iShares MSCI Israel Capped Investable Market Index Fund ( EIS )
  • iShares MSCI ACWI ex US Healthcare ETF ( AXHE )
  • Guggenheim Defensive Equity ETF ( DEF )
  • First Trust Value Line Dividend Index Fund ( FVD ).

The top-performing ETF of this group is AXHE with an increase of 8.29% over the last 100 days. EIS has the highest percent weighting of TEVA at 25%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines Stocks
Referenced Stocks: TEVA , JNJ , PFE , EIS , AXHE , DEF , FVD

More from News

Subscribe News
Contributor: News

Market News
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by